{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:59:35Z","timestamp":1758970775780,"version":"3.44.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.clinthera.2023.03.001","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T15:51:09Z","timestamp":1680018669000},"page":"376-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Alendronate Conundrum: Balancing the Competing Influences for Truly Informed Consent About Drug Safety in an Era of Rapid Change"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-7684","authenticated-orcid":false,"given":"Marcia M.","family":"Boumil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Beninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2023.03.001_bib0001","unstructured":"Merck, Sharp and Dohme Corp v. Albrecht, 2022 WL 855853 (D.N.J. March 23, 2022) and 139 S. Ct. 1668 (U.S. 2019)"},{"key":"10.1016\/j.clinthera.2023.03.001_bib0002","unstructured":"21 CFR 314.70 and FDCA Section 506A, PL 105-115 (2011)"},{"key":"10.1016\/j.clinthera.2023.03.001_bib0003","unstructured":"Merck, Sharp and Dohme Corp v. Albrecht, 2022 WL 855853 (D.N.J. March 23, 2022) citing Geier v. American Honda Motor Co, 529 US 861 (2017)"},{"key":"10.1016\/j.clinthera.2023.03.001_bib0004","unstructured":"Merck, Sharp and Dohme Corp v. Albrecht, 139 S. Ct. 1668, 1683 (U.S. 2019)"},{"key":"10.1016\/j.clinthera.2023.03.001_bib0005","unstructured":"RESTATEMENT (SECOND) OF TORTS section 402A comment K (1965). Emphasis in original."},{"key":"10.1016\/j.clinthera.2023.03.001_bib0006","unstructured":"See, e.g., Love v. Wolf, 13 Ct. App.3d (Cal. 1974); Sterling Drugs, Inc. v Cornish, 370 F.2d 82 (8th Cir 1966) and Reyes v. Wyeth Laboratories, 498 F.2d 1264 (5th Cir 1974)"},{"key":"10.1016\/j.clinthera.2023.03.001_bib0007","unstructured":"30 SW.3d 455 (Tex. App. 2000)"},{"key":"10.1016\/j.clinthera.2023.03.001_bib0008","article-title":"Prescription Drugs and the Duty to Warn: An Argument for Patient Package Inserts","volume":"111","year":"1991","journal-title":"39 Clev. St. L. Rev."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:58:28Z","timestamp":1758963508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291823000747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0149291823000747"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.03.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Alendronate Conundrum: Balancing the Competing Influences for Truly Informed Consent About Drug Safety in an Era of Rapid Change","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}